Little is known about the potentially unfavorable effects of mesenchymal stromal cell (MSC) activation on the heart. MSCs can respond to tissue injury by anti-or proinflammatory activation. We aimed to study the potential negative interaction between left ventricular dysfunction (LVD) and MSC activation.
M esenchymal stromal cells (MSCs), also known as mesenchymal stem cells, are resident in almost all tissues, including the heart, and play a major role in tissue repair and regeneration. [1] [2] [3] MSCs possess immunomodulatory, anti-inflammatory properties 4, 5 and have emerged as a viable source for cardiac cell therapy. The favorable effects of MSCs on the injured myocardium have been extensively studied and are attributed to secretion of immunomodulatory, trophic factors, and chemokines. 6 Because of their cardiovascular-associated features, 7, 8 cardiac MSCs may represent a more suitable cell source for cardiac repair. Little is known, however, about the effect of the injured and fibrotic myocardium on the function of both resident and transplanted MSCs and the potential adverse effects of the transplanted cells. MSCs can act as a sensor of myocardial injury and inflammation and respond by anti-or proinflammatory activation. 4, 9, 10 Subject to the types of inflammatory responses (acute or chronic), MSCs may either suppress inflammation and enhance repair of the injured tissue or preserve a chronic inflammatory response, leading to fibrosis and adverse tissue remodeling. 4, 11 This outcome is important because left ventricular dysfunction (LVD) and heart failure are associated with low-grade, local, and systemic inflammation, 12 able to modulate the function of resident and transplanted MSCs.
In view of the possible negative interactions between inflammation and MSCs, we need to determine whether and how LVD affects the function of MSCs. Understanding the influence of LVD on the function of resident and transplanted MSCs is essential to improve the outcome of cell-based therapy. In the present study, we aimed to determine the effect of chronic LVD on the phenotype and function of resident cardiac and peripheral MSCs and to elucidate how the activation of MSCs affects the development of LVD. We isolated MSCs from mice with chronic LVD after extensive myocardial infarction (MI). To test the hypothesis that toll-like receptor 4 (TLR4) mediates the effects of LVD on MSCs, we used cardiac MSCs from TLR4-deficient mice. Our results could help to improve the safety and efficacy of MSC-based therapy in cardiovascular regenerative medicine.
METHODS
All animal experiments were complied with the standards stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences) and were approved by the Sheba Medical Center Institutional Animal Care and Use Committee. To isolate and characterize MSCs from LVD or sham mice, we used 11-weekold, 22 g Balb/C female mice (Harlan). To induce MI for MSC transplantation experiments, we used 11-week-old, 22g Balb/C female mice (Harlan). To determine the role of TLR4 in cardiac MSCs, we used 9-week-old, transgenic TLR4 -/-(C57BL/10ScN) male mice. 13 As a control for the TLR4 -/-mice and for the isolation of spleen macrophages (MФs), we used 9-week-old C57BL/6 male mice (Harlan).
Model of MI, Sham MI, and Cell Transplantation
The model of MI and LVD in the mouse has been previously described. 3, 14, 15 In brief, mice (female Balb/C) were anesthetized by inhalation of 2% isoflurane/98% O 2 . The chest was opened by gentle dissection and left thoracotomy by the fourth intercostal space. The pericardium was removed to provide access to the left ventricular free wall. A 9-0 prolene suture was used to ligate the left anterior descending coronary artery at the lower border of the left atrium. MI was confirmed by visual blanching distal to the occlusion site and by echocardiography 24 hours after MI. For sham MI, the suture was passed around the coronary artery and removed without ligation. The thoracic incisions were closed with 5-0 silk sutures. For cell transplantation experiments, we injected the different MSCs (10 5 ) or saline (20 ul) into the ischemic border zone 1 minute after artery occlusion. Mice with LV fractional shortening >40% at day 1 after MI were excluded from the study (n=3). In the MI/sham MSC study, 38 mice were treated with either cardiac MSCs or subcutaneous fat MSCs, which were obtained from 1 mouse with MI or sham operation and followed up for 28 days. Perioperative mortality was 58% (52 out of 90). In the second study (TLR4-deficient MSC transplantation), 21 mice were treated with cardiac MSCs pooled from 3 TLR4 -/-or WT mice and followed up for 7 days. Perioperative mortality was 25% (7 out of 28). To assess the survival of MSCs, 7 days after transplantation, we injected 10 5 mCherry-labeled MSCs (20 ul) from male C57BL/6 mice into the infarcted heart of female Balb/C mice (n=3) immediately after MI.
Echocardiography
To assess LV remodeling and function after cell therapy, we performed transthoracic echocardiography with a special 
Isolation of MSCs
To evaluate the effect of LVD on resident MSCs, we isolated the cells from the heart and subcutaneous fat (inguinal fat pad) of Balb/C female mice 28 days after extensive MI (n=9) or sham operation (n=7). To determine the role of TLR4 in cardiac MSC polarization, we isolated cells from the hearts of TLR4 -/-(n=5) and C57BL/6 (WT) (n=4) male mice.
Cells were extracted with an enzymatic digestion mixture as previously described 3 using 3 cycles of incubation at 37°C for 10 minutes. Plastic-adhered cells were incubated at 37ºC in humid air with 5% CO 2 and grown in DMEM (Biological Industries) with 15% FBS (Biological Industries), 1% penicillinstreptomycin (Biological Industries), 1% L-glutathione (SigmaAldrich), 1% MEM nonessential amino acids (Invitrogen), and 0.1 mM 2-mercaptoethanol (Invitrogen). The medium was changed 3 days after plating and subsequently every 3 or 4 days. In each group of each experiment, we used cultured MSCs at passage 3 (from a minimum of 3 mice).
Characterization of MSCs
MSCs were defined according to the 3 criteria of the International Society for Cellular Therapy 16 : (1) adhesion to plastic, (2) expression of a specific combination of surface markers, and (3) differentiation potential (trilineage differentiation into adipocytes, osteoblasts, and chondrocytes). 17 
Flow Cytometry
To define the phenotype of MSCs, we analyzed cultured cells at passage 3 for common mouse MSC markers by flow cytometry using the following fluorescence antimouse antibodies: CD105-APC, CD90-FITC, CD11b-FITC, CD45-FITC, CD31-FITC, TER119-FITC, mouse IgG2aκ-APC, IgG2aκ-PE, and IgG2aκ-FITC (BioLegend).
To determine the effect of TLR4 on CD47 expression in cultured MSCs at passage 3, we analyzed MSCs from TLR4 -/-and WT mice by flow cytometry using antimouse antibody against CD47-PE (BioLegend). MSCs were analyzed with or without activation of TLR4 by LPS (10 or 100 ng/mL) for 20 hours. Labeled cells (0.5×10 6 ) from each sample were acquired and analyzed using FACS Calibur Cytofluorimeter (Cyteck Development) with Flowjo Software (Tree Star).
Differentiation Assays
To examine the in vitro differentiation potential of the different MSCs into osteogenic, adipogenic, and chondrogenic lineages, we used specifically formulated cell culture media: MesenCult Osteogenic Stimulatory Kit (Mouse), MesenCult Adipogenic Stimulatory Supplements (Mouse), and MesenCult-ACF Chondrogenic Differentiation Medium (STEMCELL Technologies Inc.). Briefly, for osteogenic and adipogenic differentiation, according to the manufacturer's instructions, MSCs were seeded at a concentration of 2.5×10 4 /cm 2 in a 24-well plate and grown for 2 to 3 weeks with osteogenic or adipogenic medium changed twice a week. Osteogenic differentiation was detected by Alizarin red S staining (0.5% in distilled water, pH=4.2), and adipogenesis was detected by Oil red O staining (0.3% in isopropanol) (Sigma-Aldrich). For chondrogenic differentiation, MSCs were grown in a 3D micromass culture system. At a concentration of 0.5×10 6 /15 mL in a polypropylene tube, cells were centrifuged at 300 g for 5 minutes and then supernatant was removed and cell pellets were treated for 14 days with chondrogenic medium changed twice a week. Chondrogenic differentiation was detected by Alcian blue staining (1% in 0.1 N HCl) (Sigma-Aldrich).
Proliferation Assay
To measure MSC growth rate, we used a cell proliferation assay. 3 Cells at passage 3 were cultured at 37°C in 96-well plates at a concentration of 3000 cells per well. Then we measured optical density in triplicate wells for each MSC group using a cell proliferation kit XTT-based colorimetric assay (Biological Industries) for 4 to 5 consecutive days. Each assay was performed on 3 to 4 primary cell cultures from each MSC group.
Cytokine Array
To define the levels of cytokine secretion from MSCs, we used Q-Plex Mouse Cytokine Inflammation (14-plex) array (Quansys Biosciences Multiplex ELISA). 3 Briefly, we cultured MSCs for 72 hours and collected their secreted medium. In the TLR4 experiment, MSCs were stimulated with an activated-MФ medium. For this purpose, we activated spleen MФs (from C57BL/6 male mice) with 100 ng/mL LPS (Sigma-Aldrich) for 6 hours and then switched to a fresh medium and allowed them to secrete growth factors for 24 hours. Then we treated the MSCs from both TLR4 -/-and WT mice with the activated-MФ medium. Concentrations of cytokines were determined by Quasys Q-View imaging and a software system. For all multiplex assays, samples were run in triplicate wells.
Histopathologic Evaluation
At the end of each study (7 or 28 days after cell transplantation), the hearts were perfused with 4% buffered formalin (Biolab), harvested, and sectioned into 2 transverse slices parallel to the atrioventricular ring. Each slice was embedded in paraffin, sectioned into 5-μm slices, and stained with hematoxylin and eosin or immunolabeled with specific antibodies.
Postmortem morphometric analysis was performed on recipient mice hearts 7 days after TLR4-deficient or WT MSC transplantation (8 days after MI). The slides were stained with Masson's Trichrome staining and hematoxylin and eosin, photographed, and analyzed with the use of planimetry software (Sigma Scan Pro version 5). We measured the average LV scar thickness (from 3 sites of scar), the relative LV scar area (scar area divided by muscle area), and the relative LV scar length (scar length divided by muscle length) in each heart.
To assess the effect of TLR4 -/-cardiac MSCs on MФ accumulation in the infarct site, heart sections (1 per mouse) were immunolabeled with rat antimouse F4/80 (AbD Serotec).
Heart sections (from each mouse) were immunolabeled with rabbit antimouse CD47/MER6 (Bioss Antibodies). To determine the survival of implanted male cardiac MSCs from TLR4 -/-or WT mouse, we stained the heart sections from female recipients with antimouse sex-determining region Y protein (E-19) (Santa Cruz Biotechnology, Inc.) and hematoxylin (for nuclear staining).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism version 7.00 (GraphPad Software). Variables are expressed as mean±SEM. Specific statistical tests are detailed in the figure legends. In brief, differences between values were tested by unpaired t test or 1-way analysis of variance test (>2 groups). If values were not normally distributed (tested by the D'AgostinoPearson omnibus normality test), then we used the nonparametric Mann-Whitney test or Kruskal-Wallis test (>2 groups), followed by a Dunn multiple comparison posttest. Differences in levels of various cytokines were tested by a 2-tailed unpaired multiple t test followed by a Holm-Sidak multiple comparison test. We used 2-way repeated-measures analysis of variance and a Holm-Sidak multiple comparison test to assess the significance of predefined comparisons at specific time points. Differences in the CD47 expression were tested by 2-way analysis of variance followed by a Holm-Sidak test.
RESULTS

Characterization of MSCs From the Failing Heart
Chronic heart failure and LVD are associated with lowgrade inflammation. 18, 19 To determine the effect of LVD on resident cardiac MSCs and subcutaneous MSCs, we isolated MSCs from female Balb/c mice with LVD 28 days after extensive MI (n=9) or sham MI (n=7). LVD was determined by reduced LV ejection fraction 28 days after MI, compared with sham operation (27.9%±3.8 versus 54.9%±3.8, P<0.0001). We then isolated and cultured MSCs from both cardiac and fat tissue after LVD or sham operation as previously described. 3, 14 MSCs were defined according to the 3 criteria of the International Society for Cellular Therapy. 16 Both cardiac MSCs and subcutaneous MSCs, isolated after either MI or sham operation, were plastic-adherent and displayed a mesenchymal spindle shape ( Figure 1A ). We next evaluated cell proliferation rate for 5 days and found that cardiac MSCs from the failing hearts had the highest growth rate compared with other groups ( Figure 1B) . Characterization of cardiac and subcutaneous MSCs after MI or sham by flow cytometry showed that cultured cells from the different groups expressed different levels of mouse MSC markers, such as CD105, a part of the complex of transforming growth factor-β receptor and a marker of MSC subset with reparative, myogenic properties. 20 All were negative for the hematopoietic lineage markers: CD11b, CD45, CD31, and TER119 ( Figure 1C ). Last, trilineage differentiation into osteoblasts, adipocytes, and chondrocytes confirmed the identity of the MSCs (Figure 1D-F) . 17 Together our findings indicate that LVD affects the phenotype of MSCs, particularly cardiac MSCs.
LV Dysfunction Modulates MSC Secretome
MSCs modulate infarct repair through their paracrine, trophic, immune-modulating, and anti-inflammatory properties. 21, 22 Therefore, we aimed to determine the effect of LVD on the cytokine profile of MSCs. For that purpose, we measured the level of secreted cytokines in the conditioned medium of cultured MSCs. Significantly, cardiac MSCs isolated from LVD secreted higher levels (≈1.3 fold) of proinflammatory cytokines, such as interleukin (IL)-1α, IL-1β, IL-6, and tumor necrosis factor-α, compared with their sham counterparts (Figure 2A-D) . The levels of the anti-inflammatory cytokines IL-10 and IL-4 remained unchanged ( Figure 2E and F) . It is interesting to note that the levels of the MΦ-recruitment factors, regulated on activation normal T-cell expressed and secreted, MΦ inflammatory protein-1α, and monocyte chemotactic protein-1, were significantly increased in cardiac MSCs from LVD (2.4-, 3.5-, and 1.6-fold higher) compared with sham-isolated cardiac MSCs ( Figure 2G-I) . It is notable that LVD induced a different secretory profile in subcutaneous MSCs (Figure 2 ). Most cytokines secreted from subcutaneous MSCs, such as tumor necrosis factor-α, IL-10, regulated on activation normal T-cell expressed and secreted, MΦ inflammatory protein-1α, and granulocyte macrophage colony-stimulating factor, showed either a decrease (≈0.6-fold lower) (Figure 2D and E, G and H, and J) or no change in cytokine levels, compared with their sham counterparts (Figure 2A, B, and F) . The secretion of IL-6, which acts as both a proinflammatory and reparative cytokine, was higher in both cardiac MSCs (1.2-fold) and subcutaneous MSCs (1.3-fold) from LVD mice, compared with sham mice (Figure 2C ). Overall, although LVD switched cardiac MSCs toward a proinflammatory phenotype, subcutaneous MSCs were differently affected by decreasing secretion of MΦ-recruitment and anti-inflammatory factors ( Figure 2K ).
LVD Reduced the Favorable Effects of Cardiac MSCs
We next aimed to determine whether LVD affects the reparative properties of MSCs in vivo. For that purpose, we isolated and expanded (3 passages) MSCs from cardiac or fat tissue of mice with either LVD or sham operation ( Figure I in the online-only Data Supplement). Then we injected 10 5 MSCs or saline (20 μl) into the ischemic border zone of recipient mice immediately after MI as previously described.
14 Cardiac function was evaluated by echocardiography on day 1 and 28 days after MI and cell transplantation. It is surprising that MSCs from all sources failed to improve cardiac function 28 days after MI, compared with saline (Table I and Figure II in the online-only Data Supplement). However, cardiac MSCs from LVD worsened anterior wall thinning, compared with mice treated with subcutaneous MSCs from LVD (Table I in the online-only Data Supplement). This finding is significant because, on the basis of Laplace's Law, scar thinning increases wall stress, subsequent infarct expansion, and LV remodeling. 23 Thus, the inflammatory environment after MI restricts the therapeutic benefits of transplanted MSCs, and proinflammatory, LVD-derived cardiac MSCs might impair healing and worsen myocardial damage.
The Role of TLR4 in Cardiac MSC Polarization
To investigate the mechanism by which the inflammatory environment of LVD restricts the therapeutic benefit of cardiac MSCs, we aimed to test the hypothesis that TLR4 mediates cardiac MSC proinflammatory polarization. The rationale for our hypothesis was that TLR4 is expressed by MSCs and could mediate the response to local inflammatory signals.
9,24 Thus, we isolated and characterized cells from the hearts of transgenic TLR4 -/-mice (C57BL/10ScN) (n=5) and control WT (C57BL) mice (n=4) ( Figure 3A) . We then evaluated MSC proliferation rate for 4 consecutive days and found a lower proliferation rate in cardiac MSCs from TLR4 -/-mice, compared with WT MSCs (Figure 3B) .
To characterize the phenotype of cardiac MSCs, we used flow cytometry. No differences occurred between TLR4 -/-and WT cardiac MSCs in the expression of mouse MSC markers (CD105 and CD90) and hematopoietic lineage markers (CD45, TER119, and CD31) ( Figure 3C ). Trilineage differentiation confirmed the identity of MSCs from both TLR -/-and WT MSCs ( Figure 3D -F). It is notable that the secretome analysis of cardiac MSCs after inflammatory stimulation revealed that TLR4 deficiency in cardiac MSCs reduced their proinflammatory phenotype (Figure 4) . To mimic the LVD or inflammatory environment after MI, we challenged cultured cardiac MSCs from TLR4 -/-and WT mice with a medium of LPS-primed MФs. We then analyzed the secreted cytokines in the conditioned media (Figure 4 ). It is remarkable that TLR4 deficiency in cardiac MSCs decreased the secretion of proinflammatory cytokines such as IL-1α, IL-12, IL-1β, and IL-6 (by 25%, 13%, 8%, and 10%), compared with WT cardiac MSCs (Figures 4A-D) . However, the levels of IL-10, an anti-inflammatory cytokine, were increased by 23% in the TLR4 -/-cardiac MSCs, whereas IL-4 remained unchanged ( Figure 4F and G) . Furthermore, TLR4 deficiency in cardiac MSCs increased MФ-recruitment chemokines such as granulocyte macrophage colony-stimulating factor and regulated on activation normal T-cell expressed and secreted by 190% and 52%, respectively, compared with WT cardiac MSCs ( Figure 4H and I) . Without MФ stimulation, secretion levels were much lower without significant differences Figure 2 Continued. and mainly decreased their anti-inflammatory (E) and macrophage-recruitment (G, H, and J) factors.
Results are presented as the mean of cytokine secretion levels (pg/mL) ±SEM. Dotted line indicates the basal level of each cytokine in the growth medium. P values addressing differences in cytokine secretion were calculated by a multiple 2-tailed unpaired t test followed by a Holm-Sidak multiple comparison test. *Statistically significant P value by a Holm-Sidak test. K, Fold change of cytokine secretion from MSCs derived from LVD, compared with sham-operated mice. LVD drives cardiac MSCs toward a proinflammatory phenotype, whereas subcutaneous MSCs were affected differently and mainly decreased their MΦ-recruitment and anti-inflammatory factors. Fold change was calculated as the ratio between cytokine levels in LVD and sham MSCs. *Statistically significant P value by a Holm-Sidak test. cardiac MSCs indicate cardiac mesenchymal stromal cells; CCL, C-C chemokine ligand; GM-CSF, granulocyte macrophage colony-stimulating factor; IL, interleukin; LVD, left ventricular dysfunction; MΦ, macrophage; MCP-1, monocyte chemotactic protein-1; MI, myocardial infarction; MIP-1α, macrophage inflammatory protein-1α; MSCs, mesenchymal stromal cells; RANTES, regulated on activation, normal T cell expressed and secreted; scMSCs, subcutaneous mesenchymal stromal cells; and TNF-α, tumor necrosis factor-α.
in the paracrine profile between the groups, except for an increase in IL-6, tumor necrosis factor-α, and MΦ inflammatory protein -1α levels, by 88%, 15%, and 93% in TLR4 -/-cardiac MSCs ( Figure 4D , E, and J). Together, our results indicate that TLR4 deficiency in cardiac MSCs diminishes the inflammatory properties and increases some chemotactic properties in activated WT cardiac MSCs. Our data suggest that TLR4 mediates, at least in A through I, To determine the effect of TLR4 deficiency on the cytokine secretion profile of cardiac MSCs, we measured the levels of secreted cytokines in the conditioned medium collected from cardiac MSCs from TLR4 -/-and WT mice by Multiplex ELISA after induction with activated-MΦ medium. Overall, TLR4 deficiency in cardiac MSCs decreased the secretion of inflammatory cytokines (A through D) after stimulation with activated-MФ medium, whereas the levels of the anti-inflammatory cytokines (F and G) (Continued ) part, cardiac MSC polarization toward a proinflammatory phenotype in response to inflammatory signals, such as occur in LVD ( Figure 4K ).
TLR4 Deficiency in cardiac MSCs Improves Their Reparative Properties in Vivo
To further assess the role of MSC -TLR4 in mediating the response of MSCs to local signals in the injured heart, we injected cardiac MSCs from TLR4 -/-or WT male mice into the hearts of recipient female mice subjected to acute MI. The efficacy of MSC transplantation from gender and strain mismatch was confirmed in a separate experiment ( Figure III in the online-only Data Supplement). We evaluated cardiac function and remodeling by echocardiography at 1 and 7 days after cell transplantation. The rationale for a 7-day follow-up was to determine the effect of local inflammation on the function of transplanted cells. Significantly, TLR4
-/-cardiac MSCs were more effective than WT MSCs in the prevention of adverse LV dilatation after MI ( Figure 5 and Table II in the online-only Data Supplement).
Compared with WT cardiac MSCs and saline, TLR4
-/-cardiac MSCs decreased the changes in LV diastolic dimension by 2.4-and 2.9-fold, respectively ( Figure 5A ) and LV diastolic volume by 2.5-and 3-fold, respectively ( Figure 5C ). Thus, deficiency of TLR4 in cardiac MSCs enhanced their ability to improve cardiac remodeling after MI.
Postmortem morphometry revealed that scar length and area were smaller and scar thickness was greater in hearts treated with TLR4 -/-cardiac MSCs, compared with controls, 7 days after MI ( Figure 6A-F) . By microscopic examination, infarcts treated with WT MSCs displayed extensive inflammation at the infarct site (Figure 6B) , whereas the saline-treated group showed a thinner, fibrotic scar 7 days after MI ( Figure 6C ). These findings probably reflect an immune response against the implanted cardiac MSCs. It is interesting to note that a microscopic evaluation revealed islands of karyolitic (loss of the nuclei) cardiomyocytes in the infarct zone of hearts treated with TLR4 -/-cardiac MSCs 7 days after MI. These islands were characterized by cardiomyocyte hypereosinophilia and absence of both nuclei and striation ( Figure 6A ). The area of the karyolitic islands in the TLR4 -/-cardiac MSC-treated mice was larger, compared with WT MSCs and saline-treated groups ( Figure 6G ).
In the experiments with TLR4 -/-and WT cardiac MSCs, we transplanted cells from male donor to female recipient mice hearts. Thus, we were able to assess cell retention by staining for the sex-determining region Y chromosome ( Figure 7A-C) . Indeed, we identified significant amounts of donor cells at the site of transplantation of TLR4 -/-cardiac MSCs around the karyolitic myocardial islands 7 days after injection ( Figure 7A, parts 1-3) . In contrast, we identified only a few donor cells in the WT cardiac MSC-treated hearts ( Figure 7B, parts 1-3) .
It is interesting to note that we identified numerous macrophages and cells expressing CD47 around the karyolitic islands ( Figure 7D and E). CD47 is a marker of cell viability and communicates antiphagocytic don't eat me signals to MΦs. [25] [26] [27] To understand the interaction between TLR4 and CD47, we analyzed cardiac MSCs from TLR4 -/-and WT by flow cytometry. CD47 expression was abundant on both WT and TLR4 -/-cardiac MSCs in vitro ( Figure 7F ). However, exposure of cardiac MSCs to 10 ng/mL of LPS (TLR4 agonist) for 20 hours significantly downregulated CD47 expression in WT but not in TLR4 -/-cardiac MSCs ( Figure 7F ). The minimal LPS dose used here mimicked the gradient of danger signals from the injury site 9 and switched MSCs into a proinflammatory phenotype. 9 A high dose of the TLR4 agonist (100 ng/ mL) did not affect the expression of CD47 on either WT or TLR4 -/-cardiac MSCs ( Figure 7F ) probably because of TLR4 downregulation as a negative feedback mechanism. 9 Together our findings indicate that TLR4 deficiency in cardiac MSCs preserves the expression of CD47 on implanted cardiac MSCs, thus improving the survival of implanted MSCs and delaying phagocytosis of ischemic cardiomyocytes, which subsequently leads to increased scar thickness and attenuation of LV dilatation.
DISCUSSION
Our study suggests that LVD modulates the phenotype and function of MSCs from cardiac tissue, and to a lesser extent from subcutaneous fat, and attenuates their reparative properties. This finding is important because Figure 4 Continued. were increased in the TLR4 -/-cardiac MSCs. The lack of TLR4 in cardiac MSCs also increased MФ-recruitment factors (H through J) after stimulation with activated-MФ medium. Results are presented as the mean of cytokine secretion levels (pg/mL) ±SEM. Solid line indicates the level of cytokine secreted by the LPS activated MФ and dashed line indicates the level of cytokine in the growth medium. P values that address differences in cytokine secretion were calculated by a multiple 2-tailed unpaired t test followed by a Holm-Sidak multiple comparison test. *Statistically significant P value by a Holm-Sidak test. K, Fold change of cytokine secretion from cardiac MSCs with and without TLR4 deficiency, after stimulation with activated MФ medium. Loss of TLR4 in cardiac MSCs resulted in decreased secretion of proinflammatory cytokines and increased secretion of some MФ recruitment and anti-inflammatory cytokines. Change in cytokine levels was calculated as the ratio of cytokine levels between TLR4 -/-and WT cardiac MSCs. *Statistically significant P value by a Holm-Sidak test. cMSCs indicate cardiac mesenchymal stromal cells; CCL5, C-C chemokine ligand 5; GM-CSF, granulocyte macrophage colony-stimulating factor; IL, interleukin; MΦ, macrophage; LPS, lipopolysaccharide; MCP-1, monocyte chemotactic protein-1; MIP-1α, macrophage inflammatory protein-1α; RANTES, regulated on activation, normal T cell expressed and secreted; TLR4, toll-like receptor 4; TNF-α, tumor necrosis factor-α; and WT, wild type.
proinflammatory MSCs can aggravate inflammation and myocardial damage, either directly or by influencing the immune response. 4, 6 Transplantation of MSCs from LVD or sham into the inflammatory environment after MI did not improve cardiac remodeling and function. Moreover, proinflammatory cardiac MSCs from LVD exacerbated scar thinning after MI. The proinflammatory polarization of cardiac MSCs was mediated by TLR4 because TLR4 deficiency attenuated proinflammatory MSC polarization and improved their ability to reduce early cardiac remodeling after MI. Our findings could be relevant to the clinical applications of MSC-based therapy and help guide the selection of MSC source when deciding between autologous versus donor MSCs for cell-based therapy. To the best of our knowledge, our study is the first to show the potential negative interaction between cardiac MSCs and the failing or infarcted heart and the key role of TLR4 in proinflammatory polarization of MSCs in the setting of LVD.
The retention and survival of MSCs in the heart are limited, 2, 28 and their favorable effects are attributed to hit-and-run paracrine effects. 6 The favorable effect of implanted MSCs on resident cardiac MSCs, MΦs, 14 and endothelial 3 and cardiac stem cells 29 is largely paracrine. In our study, the improved retention of TLR4 -/-cardiac MSCs could contribute to improved infarct repair. The poor survival of implanted WT MSCs could explain the rarity of reported adverse effects in clinical trials. Our findings could be significant for the new tissue engineering approaches to increase cell retention and survival in the injured heart, such as injectable biomaterials, scaffolds, and microspheres. With greater MSC retention and survival, however, we might see more adverse effects.
Our results are in line with the new paradigm of MSC polarization. 3, 9 Waterman et al 9 showed that MSCs can polarize into 2 functional phenotypes after specific TLR stimulation, resulting in different immune modulatory The present work confirms and extends our previous work and that of others, 3, 7, 30, 31 suggesting that MSCs from different tissues have a different phenotype, proliferation rate, and function. The present study and our previous work with human MSCs 3 suggest that heart disease affects the phenotype and function of MSCs from different tissues.
The Role of TLR4 in MSC Polarization
TLR4 emerged as a potential regulator that could mediate MSC proinflammatory polarization. TLRs play a critical role in the activation of innate and adaptive immunity 32 and trigger inflammation, leading to dysfunctional wound healing in several chronic diseases. 33 Loss of TLR4 provides protection against ischemia/reperfusion injury and remodeling after MI. 34, 35 However, it is unclear which cardiac cell is responsible for such protection. It is important to note that immune cells as well as a variety of other cell types express TLR, including MSCs. 3, 24, 36 The activation of the TLR4 pathway stimulates secretion of proinflammatory mediators by MSCs 9,37,38 and can modulate their reparative functions. 3, 9, 30, 39 In the setting of acute or chronic myocardial injury, TLR4 can be activated by endogenous ligands called damage-associated molecular patterns. 40 These endogenous activators, such as heat shock proteins, are derived from dying cells 10 and can promote chronic heart failure. 41 The present study shows that MSCs from TLR4 -/-mice but not from WT mice improve early LV remodeling after MI. Moreover, transplanted TLR4 -/-cardiac MSCs increased scar thickness. This finding is important because, on the basis of Laplace's law, increased scar thickening reduces wall stress and subsequent infarct expansion and LV remodeling. 23 14, 42 and inhibit the phagocytic capacity of MΦs. 42 The inhibitory effect of TLR4 -/-cardiac MSCs on MΦ phagocytic capacity could partially explain the unique finding of karyolitic cardiomyocyte islands. It is interesting to note that the cells that encircled the islands of karyolitic cardiomyocytes expressed CD47, a marker of the don't eat me signal, 43 which prevents phagocytosis and is associated with improved myocardial protection and antifibrotic effects on the heart. 44 We have shown that although a low dose of the TLR4 agonist LPS, which mimics chronic inflammation, downregulates CD47 expression in MSCs, TLR4 deficiency preserves it. Maintenance of CD47 expression could be an advantage to avoid a cleanup response by cardiac MΦs. 6 It seems that CD47 expression improves implanted MSC survival, delays cardiomyocyte phagocytosis, increases scar thickness, and enhances a short-term therapeutic effect. Nevertheless, the significance of MSC CD47 expression and delayed phagocytosis after TLR4 -/-MSC therapy needs a longer follow-up period because inefficient clearance of dying cardiomyocytes has been associated with suboptimal tissue remodeling after MI. 45 Taken together, our study proposes that TLR4 deficiency in resident and transplanted MSCs could diminish the negative effects of cardiac inflammation on the MSC's reparative properties, create an improved environment for MSC retention, and improve the outcome of MSC therapy after MI (Figure 8 ).
Limitations
First, characteristics of MSCs were based on cultured cells. Cell culture duration and the degree of cell expansion have an impact on MSC phenotype and functional properties. 6 Nevertheless, MSCs from different sources were cultured under identical conditions, and our findings clearly demonstrated the differences in characteristics and function between MSCs from LVD compared with controls. Second, cardiac MSCs are a heterogeneous cell population derived from various sources. Thus, the diverse origins for subpopulations of cardiac MSCs and the influence on their ability for tissue repair warrant further research. Third, to verify similar myocardial injury among the experimental groups, we performed the first echocardiography study after MI. However, a preinjury echocardiography is warranted to confirm similar baseline parameters among experimental groups. Fourth, although we used a low level of anesthesia, echocardiography in conscious mice could avoid the adverse effects of anesthesia and may produce more physiological results. 46 Last, 7 days of follow-up in the experiment of TLR4 -/-cardiac MSC transplantation might be too short; the beneficial effects of TLR4 -/-cardiac MSCs could disappear during a longer follow-up period. Figure 6 Continued. measurements of the cardiomyocyte karyolitic islands (G) in mice hearts from the different groups showed significantly larger areas of karyolitic islands in hearts treated with TLR4 -/-cardiac MSC, compared with WT cardiac MSCand saline-treated groups. P value for the difference between groups was calculated by the nonparametric Kruskal-Wallis test followed by a Dunn multiple comparisons test. cMSCs indicate cardiac mesenchymal stromal cells; H&E, hematoxylin and eosin; TLR4, toll-like receptor 4; and WT, wild type. A through C (parts 1-3), Donor MSCs in the infarcted myocardium 7 days after transplantation in mice. To determine the survival of implanted cardiac MSCs (male) in infarcted myocardium (female), we stained the hearts against SRY 7 days after transplantation. Representative microscopic images of the infarct zone: brown nuclear staining indicates transplanted, SRY-positive cardiac MSCs, and purple nuclear staining indicates host cells. Cardiac MSCs were found at the border of the karyolitic sites and were abundant in the heart sections treated with TLR4 -/-cardiac MSCs (A through C [part 3], red arrows). D and E, Immunostaining of the karyolitic sites revealed large numbers of infiltrating cells at the border zone, some of them stained by the MΦ marker F4/80 (D) and some expressed the don't eat me marker CD47 (E). F, Evaluation of CD47 expression on cultured MSCs: both WT and TLR4 -/-cardiac MSCs expressed CD47. Exposure of cardiac MSCs to a low dose of LPS (10 ng/mL) downregulated CD47 expression in WT but not in TLR4 -/-cardiac MSCs. P value for the difference among the groups was calculated by 2-way ANOVA test followed by a Holm-Sidak multiple comparison test. cMSCs indicate cardiac mesenchymal stromal cells; LPS, lipopolysaccharide; SRY, sex-determining region Y; TLR4, toll-like receptor 4; and WT, wild type.
Summary, Implications, and Future Research
Our study shows that the environment of the failing and infarcted myocardium drives resident and transplanted MSCs toward a proinflammatory phenotype and restricts their reparative properties in a mechanism mediated by TLR4. Further understanding of the molecular mechanisms that govern the interactions between MSCs and inflammation is essential for developing new MSC-based therapies and improving our knowledge of myocardial inflammation and fibrosis. The ability to improve infarct healing and treat LVD by optimizing MSC therapy could help us to advance the field of cardiovascular regenerative medicine, particularly in older and chronically ill patients whose MSC regenerative capacity could be impaired. Resident and transplanted MSCs from cardiac patients are affected by local factors released by damaged cells during MI. These factors, also called DAMPs, are known to bind to TLR4, which together polarize the MSCs toward a proinflammatory phenotype and reduce their CD47 expression (don't eat me signal), thereby impairing their reparative potential and survival. *Findings from previous study. DAMPs indicate damage-associated molecular pattern molecules; LVD, left ventricular dysfunction; MΦ, macrophage; MI, myocardial infarction; MSCs, mesenchymal stromal cells; and TLR4, toll-like receptor 4.
